Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

NCT06690515 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
465
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PT Bio Farma

Collaborators